Cargando…
A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report
BACKGROUND: Bupropion is approved for the treatment of mood disorders and as an adjuvant medication for smoking cessation. Bupropion is generally well tolerated and considered safe. Two randomized controlled trials of bupropion therapy for smoking cessation did not report any hepatic adverse events....
Autores principales: | Humayun, Fawwaz, Shehab, Thomas M, Tworek, Joseph A, Fontana, Robert J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008202/ https://www.ncbi.nlm.nih.gov/pubmed/17877816 http://dx.doi.org/10.1186/1752-1947-1-88 |
Ejemplares similares
-
Rapid bupropion-induced hepatotoxicity: a case report and review of the literature
por: Anandabaskaran, Sulakchanan, et al.
Publicado: (2018) -
Bupropion-Induced Dystonia: A Case Report
por: Zahra, Tafseer, et al.
Publicado: (2022) -
Symptoms of exhibitionism that regress with bupropion: A case report
por: Vayısoğlu, Sefa
Publicado: (2023) -
A Fatal Case of Nafcillin-Induced Hepatotoxicity: A Case Report and the Literature Review
por: Alam, Mian Bilal, et al.
Publicado: (2012) -
Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature
por: Kabbara, Wissam K., et al.
Publicado: (2016)